Reuters logo
BRIEF-Molecular Partners: additional details about clinical oncology program MP0250
October 10, 2016 / 5:21 AM / a year ago

BRIEF-Molecular Partners: additional details about clinical oncology program MP0250

Oct 10(Reuters) - Molecular Partners AG :

* Announced on Sunday additional details about its ongoing clinical oncology program MP0250

* Based on the encouraging data from phase 1 in solid tumors, Molecular Partners decided to initiate an additional phase 2 study for a solid tumor indication

* Study details will be disclosed in H1 2017

Source text for Eikon:

Further company coverage:

Gdynia Newsroom

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below